Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYPERION: Deferasirox combination for cardiac iron overload
NCT01254227Phase 2Completed
- Sponsor
- Novartis
- Start
- Jan 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of deferasirox in iron overload, sponsored by Novartis. Started Jan 2011; status: completed.
02
Drugs
deferasirox
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT01254227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01254227.